Peregrine Pharmaceuticals CEO Steven King receives $437K in 2007
Peregrine Pharmaceuticals reports 2007 executive compensation
By ExecPay News
Published: August 28, 2007
Peregrine Pharmaceuticals reported fiscal year 2007 executive compensation information on August 28, 2007.
In 2007, three executives at Peregrine Pharmaceuticals received on average a compensation package of $358K.
Average pay of disclosed executives at Peregrine Pharmaceuticals
Steven W. King, Chief Executive Officer, received $437K in total. 86% of King's compensation, or $374K, was in salary. King also received $47K in stock awards and $16K in other compensation.
Paul J. Lytle, Chief Financial Officer, received a compensation package of $347K. 85% of the compensation package, or $293K, was in salary.
F. David King, Vice President, Business Development, earned $292K in 2007.
Peregrine Pharmaceuticals' fiscal year ends on April 30.
Related executives
You may also like
Source: SEC filing on August 28, 2007.